Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × INDUSTRY × CP protocol × Clear all

Phase

Status

Completed 8 Recruiting 4 Active not recruiting 4 Terminated 2 Withdrawn 1 Unknown 1 Not yet recruiting 1

Sponsor Class

OTHER 3 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Injections 33 Carboplatin 26 Docetaxel 23 Paclitaxel 20 Capecitabine 20 pembrolizumab 19 Oxaliplatin 19 Cisplatin 18 Gemcitabine 14 Bevacizumab 14 Pemetrexed 13 Cyclophosphamide 11 Fluorouracil 10 tislelizumab 9 Drug Therapy 9 Leucovorin 8 Irinotecan 8 Doxorubicin 7 osimertinib 6 Trastuzumab 6 Nivolumab 6 palbociclib 5 lenvatinib 5 fludarabine 5 Topotecan 5 Prednisolone 5 Fulvestrant 5 Dexamethasone 5 130-nm albumin-bound paclitaxel 5 regorafenib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07365319 2026-01-26

TeLuRide-008

Eikon Therapeutics

Phase 2/3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡